{
    "organizations": [],
    "uuid": "ee7b67a1cf567733d59407604a5e9f34f88de975",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunovia-q1-operating-loss-widens/brief-immunovia-q1-operating-loss-widens-to-sek-17-4-million-idUSFWN1S404X",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunovia Q1 Operating Loss Widens To SEK 17.4 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - IMMUNOVIA AB (PUBL):\n* Q1 NET SALES SEK 112,000 VERSUS SEK 28,000 YEAR AGO * COMPANY HAS A TARGET OF ACHIEVING TURNOVER OF SEK 250-300 MILLION BY 2021\n* TARGET OF TOTAL TURNOVER OF SEK 800-1,000 BY 2023\n* Q1 OPERATING LOSS SEK 17.4 MILLION VERSUS LOSS SEK 7.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-27T14:11:00.000+03:00",
    "crawled": "2018-04-28T12:56:10.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "immunovia",
        "ab",
        "publ",
        "q1",
        "net",
        "sale",
        "sek",
        "versus",
        "sek",
        "year",
        "ago",
        "company",
        "target",
        "achieving",
        "turnover",
        "sek",
        "million",
        "target",
        "total",
        "turnover",
        "sek",
        "q1",
        "operating",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}